Robert Gut's Net Worth
$2.35 Million
Who is Robert Gut?
Robert Gut has an estimated net worth of $2.35 Million. This is based on reported shares across multiple companies, which include uniQure N.V., and Versartis, Inc..
SEC CIK
Robert Gut's CIK is 0001716268
Past Insider Trading and Trends
2020 was Robert Gut's most active year for acquiring shares with 5 total transactions. Robert Gut's most active month to acquire stocks was the month of May. 2020 was Robert Gut's most active year for disposing of shares, totalling 6 transactions. Robert Gut's most active month to dispose stocks was the month of December. 2020 saw Robert Gut paying a total of $1,051,343.75 for 66,584 shares, this is the most they've acquired in one year. In 2020 Robert Gut cashed out on 65,595 shares for a total of $2,502,454.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
uniQure N.V. (QURE) Snapshot price: $5.66
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.97% | 5.47K |
$18.88 | -$60,944.64 | 47.67K |
Jun 13 - Jun 16
| |||
Form 4
| -4.46% | -1.97K |
$20.79 | -$40,907.19 | 42.2K |
Feb 27 - Feb 28
| |||
Form 4
| +25.88% | 9.08K |
—
|
—
| 44.16K |
Jun 15
| |||
Form 4
| -4.37% | -1.60K |
$16.70 | -$26,753.40 | 35.09K |
Feb 28
| |||
Form 4
| +4.36% | 1.53K |
—
|
—
| 36.69K |
Feb 24
| |||
Form 4
| -6.26% | -2.35K |
$18.12 | -$42,545.76 | 35.15K |
Jan 26
| |||
Form 4
| -10.71% | -4.50K |
$36.61 | -$164,745.00 | 37.5K |
Sep 21
| |||
Form 4
| -3.00% | -1.30K |
$36.98 | -$48,074.00 | 42K |
Mar 2
| |||
Form 4
| +5.82% | 2.38K |
—
|
—
| 43.3K |
Feb 25
| |||
Form 4
| -1.45% | -604.00 |
$39.09 | -$23,610.36 | 40.92K |
Jan 26
| |||
Form 4
| -9.49% | -4.35K |
$39.12 | -$170,250.24 | 41.52K |
Sep 21
| |||
Form 4
|
—
|
0
|
$54.56 | -$829,906.25 | 45.88K |
Scheduled
|
Jun 23
| ||
Form 4
| +36.96% | 12.38K |
—
|
—
| 45.88K |
Feb 27
| |||
Form 4
| +20.12% | 5.61K |
—
|
—
| 33.49K |
Jan 31
| |||
Form 4
| -21.18% | -7.49K |
$60.18 | -$450,954.21 | 27.89K |
Scheduled
|
Jan 27 - Jan 28
| ||
Form 4
| -11.88% | -4.77K |
$47.16 | -$224,906.04 | 35.38K |
Sep 19
| |||
Form 4
| +14.71% | 5.15K |
—
|
—
| 40.15K |
Jan 25
| |||
Form 4
|
∞
| 35K |
—
|
—
| 35K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Versartis, Inc. (ARAV) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +67.13% | 91.3K |
—
|
—
| 227.3K |
Dec 20
| |||
Form 4
| +183.33% | 88K |
—
|
—
| 136K |
Oct 6
| |||
Form 4
|
∞
| 48K |
—
|
—
| 48K |
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||